Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, May 2001, p. 560-563, Vol. 8, No. 3
Central Pennsylvania Alliance
Laboratory1 and Clinical Microbiology
Laboratory, York Hospital,2 York, and
Departments of Medicine and Pathology, Milton S. Hershey
Medical Center of the Pennsylvania State University,
Hershey,3 Pennsylvania
Received 15 November 2000/Returned for modification 19 January
2001/Accepted 21 February 2001
Normal assay variation associated with bDNA tests for human
immunodeficiency virus type 1 (HIV-1) RNA performed at two laboratories with different levels of test experience was investigated. Two 5-ml
aliquots of blood in EDTA tubes were collected from each patient for
whom the HIV-1 bDNA test was ordered. Blood was stored for no more than
4 h at room temperature prior to plasma separation. Plasma was
stored at
1071-412X/01/$04.00+0 DOI: 10.1128/CDLI.8.3.560-563.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Intra- and Interlaboratory Variabilities of Results
Obtained with the Quantiplex Human Immunodeficiency Virus Type 1 RNA bDNA Assay, Version 3.0
70°C until transported to the Central Pennsylvania Alliance Laboratory (CPAL; York, Pa.) and to the Hershey Medical Center
(Hershey, Pa.) on dry ice. Samples were stored at 
70°C at both
laboratories prior to testing. Pools of negative (donor), low-HIV-1-RNA-positive, and high-HIV-1-RNA-positive plasma samples were
also repeatedly tested at CPAL to determine both intra- and interrun
variation. From 11 August 1999 until 14 September 2000, 448 patient
specimens were analyzed in parallel at CPAL and Hershey. From 206 samples with results of
1,000 copies/ml at CPAL, 148 (72%) of the
results varied by
0.20 log10 when tested at Hershey and
none varied by >0.50 log10. However, of 242 specimens with results of <1,000 copies/ml at CPAL, 11 (5%) of the results varied by
>0.50 log10 when tested at Hershey. Of 38 aliquots of
HIV-1 RNA pool negative samples included in 13 CPAL bDNA runs, 37 (97%) gave results of <50 copies/ml and 1 (3%) gave a result of 114 copies/ml. Low-positive HIV-1 RNA pool intrarun variation ranged from
0.06 to 0.26 log10 while the maximum interrun variation was 0.52 log10. High-positive HIV-1 RNA pool intrarun variation
ranged from 0.04 to 0.32 log10, while the maximum interrun
variation was 0.55 log10. In our patient population, a
change in bDNA HIV-1 RNA results of
0.50 log10 over time
most likely represents normal laboratory test variation. However, a
change of >0.50 log10, especially if the results are
>1,000 copies/ml, is likely to be significant.
*
Corresponding author. Mailing address: Clinical
Microbiology Laboratory, York Hospital, 1001 S. George St., York,
PA 17405. Phone: (717) 851-2393. Fax: (717) 851-2707. E-mail:
jkellogg{at}wellspan.org.
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |